Asharq Al-Awsat: Holiday Travel Raises Clot Risk, CDC Factors and Garcia Guidance

Holiday travel increases the risk of venous thromboembolism, but the absolute danger remains low for most people, according to CDC risk factors and guidance from hematologist David Garcia published by Asharq Al-Awsat.

The Centers for Disease Control and Prevention identifies personal or family history of clots, recent surgery or hospitalization, pregnancy, estrogen-based contraceptives or hormone therapy, cancer, heart failure, inflammatory bowel disease, obesity, and older age as key risk amplifiers.

Dehydration narrows blood vessels and thickens blood, elevating clotting potential. Garcia advises avoiding large amounts of carbonated beverages and filling water bottles after airport security checkpoints. The CDC recommends standing and walking every two to three hours on flights exceeding four to five hours, where a slight risk increase appears.

In Plain English: The Clinical Takeaway

  • Hydration and movement are the primary non-pharmacologic defenses against travel-related deep vein thrombosis (DVT).
  • Compression stockings provide mechanical prophylaxis but require proper fitting to be effective.
  • Patients on prescribed anticoagulants should maintain their dosing schedule; the medication generally neutralizes the added flight risk.

Mechanism of Hypobaric Hypoxia and Endothelial Activation

Commercial aircraft cabins are pressurized to an equivalent altitude of 6,000 to 8,000 feet, reducing the partial pressure of oxygen. This hypobaric hypoxia triggers endothelial activation and increases blood viscosity, creating a prothrombotic state distinct from simple immobilization. A landmark study in The Lancet demonstrated that hypobaric hypoxia activates coagulation factors VIII and IX and reduces fibrinolysis, effects not fully replicated by ground-level immobilization alone.

Epidemiological data from the WRIGHT project, coordinated by the World Health Organization, confirmed that the risk of VTE doubles after flights longer than four hours. The risk rises sharply with duration: flights over 16 hours carry a relative risk near 3.0 compared to non-travel periods.

Pharmacologic and Mechanical Prophylaxis Evidence

A Cochrane review of randomized trials found GCS reduced asymptomatic DVT in long-haul flyers, though evidence for preventing symptomatic VTE or pulmonary embolism (PE) remains limited due to low event rates, according to Aawsat.

Low-molecular-weight heparin (LMWH) prophylaxis is reserved for the highest-risk patients.

Intervention Population Relative Risk Reduction (Asymptomatic DVT) Guideline Strength (CHEST)
Aspirin Unselected travelers Not significant for VTE Not recommended
Hydration / Ambulation All travelers Observational benefit Good practice statement

Contraindications & When to Consult a Doctor

Patients on therapeutic anticoagulation who develop signs of bleeding — unusual bruising, hematuria, or melena — must seek urgent evaluation. Unilateral leg swelling, calf tenderness, or sudden dyspnea and pleuritic chest pain during or after travel warrant immediate emergency department assessment for DVT or PE via compression ultrasound or CT pulmonary angiography, respectively.

David Garcia is a professor of hematology and oncology at the University of Washington and serves as the medical director of anti-thrombotic therapy for UW Medicine. He holds leadership roles at Fred Hutch Cancer Center, including section head and co-clinical director of classical hematology.

Garcia earned his medical degree from the University of Alabama, completed an internal medicine residency at Johns Hopkins, and finished a hematology fellowship at UW and Fred Hutch. His clinical and research focus centers on thrombotic disorders, including antiphospholipid syndrome and cancer-associated venous thromboembolism.

Garcia emphasized that patients adhering to prescribed anticoagulants can travel confidently. “Any extra risk that air travel might cause is completely negated by the effect of the medication,” he told Asharq Al-Awsat. He added that aspirin should not be initiated for travel prophylaxis without a physician’s recommendation, as its benefit for venous thrombosis prevention is unproven and it carries gastrointestinal bleeding risk.

References

  • World Health Organization. WHO Research Into Global Hazards of Travel (WRIGHT) Project Final Report. Geneva; 2011.
  • Kesteven P, et al. “Hypobaric hypoxia activates coagulation.” The Lancet. 2004;364(9437):863-864.
  • Kakkar AK, et al.
  • "Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report." Chest. 2016;149(2):315-352.
  • Centers for Disease Control and Prevention. Blood Clots During Travel. Atlanta, GA; updated 2023.
Photo of author

Health Desk

Health Desk at Archyde.

Zverev Beats Fils 6-4, 7-6 to Finish ATP Finals Group Unbeaten

TEAMtalk: Man Utd Plot January Hijack for Tottenham Target Igor Matanovic